jueves, 2 de abril de 2020

FDA asks manufacturers to recall heartburn drugs over traces of possible carcinogen

FDA asks manufacturers to recall heartburn drugs over traces of possible carcinogen

Daily Recap

STAT Plus: FDA asks manufacturers to recall heartburn drugs over traces of a possible carcinogen

By ED SILVERMAN


DREW ANGERER/GETTY IMAGES
The move comes six months after an online pharmacy that ran its own tests of the drugs petitioned the FDA to push for a full-blown recall.

No hay comentarios: